Bloomberg BNA Medical Devices Law & Industry Report quoted life sciences partner Gregory Levine (Washington, D.C.) in a column on 2016 medical device law trends. Mr. Levine predicts that the FDA will continue to advance its proposed framework on laboratory-developed tests (LDTs), while lab groups will continue to threaten litigation and the FDA will continue enforcement against direct-to-consumer laboratory tests. (Subscription required)
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.